Ignite Creation Date:
2025-12-24 @ 1:15 PM
Ignite Modification Date:
2026-02-28 @ 5:33 AM
Study NCT ID:
NCT02750995
Status:
COMPLETED
Last Update Posted:
2020-11-25
First Post:
2016-04-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
Sponsor:
Daniel El Fassi
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | myelodysplastic syndrome | View |
| None | acute myeloid leukemia | View |
| None | azacitidine | View |
| None | peptide vaccine | View |
| None | cancer testis antigen | View |
| None | cancer vaccine | View |
| None | immunotherapy | View |
| None | combination therapy | View |
| None | NY-ESO-1 | View |
| None | PRAME | View |
| None | MAGE-A3 | View |
| None | WT-1 | View |
| None | vaccine | View |